Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Conditions:   Stroke (CVA) or TIA;   Headache, Migraine;   Botulinum Toxins, Type A;   Cerebral Venous Sinus Thrombosis;   Carotid Dissection Artery;   Vertebral Dissection Artery;   Hemorrhagic Stroke;   Reversible Cerebral Vasoconstriction Syndrome Interventions:   Drug: Botox 200 UNT Injection;   Combination Product: Non Botox based Standard of Care Treatments for Headache/Migraine Sponsor:   University of Alberta Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials